Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gaedigk

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|March 8, 2000
Interethnic differences of drug-metabolizing enzymesA Gaedigk
Psychopharmacology Bulletin|October 8, 1999
High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary dataL D Bradford, A Gaedigk, J S Leeder
Genomics|March 1, 1997
Cloning, structural organization, and chromosomal mapping of the human phenol sulfotransferase STP2 geneA Gaedigk, B G Beatty, D M Grant
DNA and Cell Biology|December 24, 1997
Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolaseA Gaedigk, J S Leeder, D M Grant
Pharmacogenetics|June 1, 1994
Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsA Gaedigk, S P Spielberg, D M Grant
Pharmacogenetics|July 31, 1998
Non-monooxygenase cytochromes P450 as potential human autoantigens in anticonvulsant hypersensitivity reactionsJ S Leeder, X Lu, Y Timsit, et al.
Chemico-Biological Interactions|May 5, 1998
Novel sulfotransferases cloned by RT-PCR: real proteins or PCR artifacts?A Gaedigk, P Lekas, M Berchuk, et al.
Molecular Pharmacology|February 1, 1996
Epitope mapping studies with human anti-cytochrome P450 3A antibodiesJ S Leeder, A Gaedigk, X Lu, et al.
American Journal of Human Genetics|May 1, 1991
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphismA Gaedigk, M Blum, R Gaedigk, et al.
The Biochemical Journal|January 12, 1999
Structural characterization of human aryl sulphotransferasesL A Brix, R G Duggleby, A Gaedigk, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology and Therapeutics|March 8, 2000
Interethnic differences of drug-metabolizing enzymesA Gaedigk
Psychopharmacology Bulletin|October 8, 1999
High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary dataL D Bradford, A Gaedigk, J S Leeder
Genomics|March 1, 1997
Cloning, structural organization, and chromosomal mapping of the human phenol sulfotransferase STP2 geneA Gaedigk, B G Beatty, D M Grant
DNA and Cell Biology|December 24, 1997
Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolaseA Gaedigk, J S Leeder, D M Grant
Pharmacogenetics|June 1, 1994
Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsA Gaedigk, S P Spielberg, D M Grant
Pharmacogenetics|July 31, 1998
Non-monooxygenase cytochromes P450 as potential human autoantigens in anticonvulsant hypersensitivity reactionsJ S Leeder, X Lu, Y Timsit, et al.
Chemico-Biological Interactions|May 5, 1998
Novel sulfotransferases cloned by RT-PCR: real proteins or PCR artifacts?A Gaedigk, P Lekas, M Berchuk, et al.
Molecular Pharmacology|February 1, 1996
Epitope mapping studies with human anti-cytochrome P450 3A antibodiesJ S Leeder, A Gaedigk, X Lu, et al.
American Journal of Human Genetics|May 1, 1991
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphismA Gaedigk, M Blum, R Gaedigk, et al.
The Biochemical Journal|January 12, 1999
Structural characterization of human aryl sulphotransferasesL A Brix, R G Duggleby, A Gaedigk, et al.
Pageof 5